ANDHealth+ 2017 Cohort Announced
ANDHealth congratulates the ANDHealth+ 2017 cohort, DoseMe, Human Gas Capsule, PenPal, Perx, Seer Medical and Skin View.
ANDHealth’s first cohort of companies will benefit from a hands-on advisory group drawn from ANDHealth’s industry members, which include Novartis Pharmaceuticals, RMIT University, Planet Innovation, Curve Tomorrow, The Murdoch Children’s Research Institute, GP2U, HPM Executive, AusBiotech and HealthXL, that will work alongside each company to define and support a project which makes a significant contribution to their market readiness. In addition to the time and resources of the advisors, companies also can access $60k of project funds, media and communications support, intellectual property advice and access to a global network of digital health experts.
For the Press release, click here.